Zeo ScientifiX, Inc. Cash Flow Statement
ZEOX|13 years of annual SEC 10-K data (FY2012-FY2024)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$1M
FY2024
Free Cash Flow
N/A
FY2024
Capital Expenditures
N/A
Cash used for long-term assets
Dividends Paid
N/A
FY2024
Zeo ScientifiX, Inc. used $1M in operating cash flow in FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -40.46 (distress zone, below 1.23 threshold)
- Negative shareholders equity: Liabilities exceed assets
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.7M | -$7.0M | -$8.9M | -$12.8M | -$12.6M | -$1.7M | -$3.5M | -$9.0M | -$1.3M | -$738.4K | -$65.8K | -$32.2K | -$13.3K |
| Depreciation & Amortization | $74.0K | $486.0K | $332.5K | $52.7K | - | - | - | - | - | - | - | - | - |
| Operating Cash Flow | -$1.4M | -$2.2M | -$3.2M | -$2.7M | -$1.8M | -$565.5K | -$512.0K | -$881.5K | -$548.2K | -$446.5K | -$62.5K | -$30.0K | -$8.7K |
| Capital Expenditures | - | $26.0K | $824.7K | $424.7K | $138.7K | $32.7K | $4.6K | $45.1K | $26.3K | $1.7K | - | - | - |
| Free Cash Flow | - | -$2.2M | -$4.0M | -$3.1M | -$2.0M | -$598.2K | -$516.6K | -$926.7K | -$574.5K | -$448.2K | - | - | - |
| FCF Margin | - | -48.8% | -61.5% | -55.5% | -63.8% | -35.1% | -53.6% | -162.6% | -310.7% | -303.6% | - | - | - |